focus mul - UKSH Universitätsklinikum Schleswig-Holstein

45. Kuhfahl J, Steinbrecher C, Wagner T, Wagner H, Fritze D, Link H, Schulte F,
Pichlmeier U, Kreuser ED (2004) Second-line treatment of advanced
colorectal cancer with a weekly simultaneous 24-hour infusion of 5fluorouracil
and sodium-folinate: a multicentre phase II trial. Onkologie 27:
449-454
46. Lange T, Perras B, Born J, Fehm HL (2003) Sleep enhances the human
antibody response to hepatitis A vaccination. Psychosom Med 65: 831-835
47. Linder R, Dodt C, Kurowski V, Djonlagic H (2003) Internistische Intensivtherapie
Vorteil eigenständiger Stationen. Deutsches Ärzteblatt 100: A
1792-1793
48. Mace JR, Keohan ML, Bernardy H, Junge K, Niebch G, Romeis P, Thoma A,
Wanger T, Mueller U, Demetri G, Baker LH (2003) Crossover Randomized
Comparison of Intravenous versus Intravenous/Oral Mesna in Soft Tissue
Sarcoma Treated with High-Dose Ifostamide. Clin Cancer Res 9: 5829-
5834
49. Kempgens B, Kisro J, Gruber Y, Bahrs H, Wagner T (2003) Two schedules
of application for mesna and their influence on the thiol-metabolism. J Clin
Pharm Ther 41: 608-609
50. Lorch H, Steinhoff J, Fricke L, Wolny A, Kagel C, Weiss HD, Zwaan M (2003)
CO2 angiography of transplanted kidneys. Röntgenpraxis 55: 26-32
51. Marxsen JH, Stengel P, Doege K, Heikkinen P, Jokilehto T, Wagner T, Jelkmann
W, Jaakkola P, Metzen E (2004) Hypoxia-inducible factor-1 (HIF-1)
promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Biochem J 381:761-767
52. Maurmann S, Fricke L, Wagner HJ, Schlenke P, Hennig H, Steinhoff J, Jabs
WJ (2003) Molecular parameters for precise diagnosis of asymptomatic
Epstein-Barr virus reactivation in healthy carriers. J Clin Microbiol 41:
5419-5428
53. Meier M, Oepen B, Horn W, Steinhoff U, Schütt M (2004) Strukturkonzept zur
Etablierung einer flächendeckenden ambulanten Versorgung von
Patienten mit Typ-2-Diabetes: Ein-Jahres-Evaluation eines regionalen
Schulungsvereins. Dtsch Med Wochenschr 12: 547-551
54. Merl V, Kern W, Peters A, Oltmanns KM, Gais S, Born J, Fehm HL, Schultes
B (2004) Differences between nighttime and daytime hypoglycemia
counterregulation in healthy humans. Metabolism 53: 894 - 898
55. Merl V, Peters A, Oltmanns KM, Kern W, Hubold C, Hallschmid M, Born J,
Fehm HL, Schultes B (2004) Preserved circadian rhythm of serum insulin
concentration at low plasma glucose during fasting in lean and overweight
humans. Metabolism 53: 1449 - 1453
56. Metzen E, Stiehl DP, Doege K, Marxsen JH, Hellwig-Burgel T, Jelkmann W
(2004) Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1)
gene: Identification of a functional hypoxia-responsive element. Biochem
J 2004 Nov 24; [Epub ahead of print]
57. Metzen E, Berchner-Pfannschmidt U, Stengel P, Marxsen JH, Stolze I,
Klinger M, Huang WQ, Wotzlaw C, Hellwig-Bürgel T, Jelkmann W, Acker
H, Fandrey J (2003) Intracellular localisation of human HIF-1alpha
hydroxylases: implications for oxygen sensing. J Cell Sci 116: 1319-1326
304